Pulmonx (LUNG) Earnings Date & Reports

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD)... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LUNG is expected to report earnings to rise 19.17% to -28 cents per share on November 04

Q3'26

Est.

$-0.29

Q2'26

Beat

by $0.04

Q1'26

Beat

by $0.02

Q4'25

Beat

by $0.14

Q3'25

Beat

by $0.08

The last earnings report on July 29 showed earnings per share of -23 cents, beating the estimate of -28 cents. With 375.33K shares outstanding, the current market capitalization sits at 92.77M.

View a ticker or compare two or three

LUNG

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days